NCT07301229 2025-12-24
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
Shanghai Henlius Biotech
Phase 2 Not yet recruiting
Shanghai Henlius Biotech
Institut Curie
The University of Texas Health Science Center, Houston